Wockhardt recalls hypertension drug in US

Wockhardt recalls hypertension drug in US

FPJ BureauUpdated: Saturday, June 01, 2019, 12:50 PM IST
article-image

Hyderabad:  Wockhardt Ltd is recalling 109,744 bottles of anti-hypertensive drug belonging to multiple lots from the American market following failure of dissolution test, US regulator FDA said.  According to a notification by the USFDA, the recall is voluntarily and was initiated by the company from April 1 under ‘Class-II’ classification.             The recall of metoprolol is a generic version of AstraZeneca Plc’s branded drug Toprol.

RECENT STORIES

Transformers & Rectifiers Secures ₹53.33 Crore Order From The Power Grid Corporation

Transformers & Rectifiers Secures ₹53.33 Crore Order From The Power Grid Corporation

India-Russia Relationship Stable Over The Past 78 Years, Expanding Engagement Beyond Traditional...

India-Russia Relationship Stable Over The Past 78 Years, Expanding Engagement Beyond Traditional...

Metal Stocks Soar 6.6%, Hindustan Copper & SAIL Lead The Rally On Rising Global Copper Prices

Metal Stocks Soar 6.6%, Hindustan Copper & SAIL Lead The Rally On Rising Global Copper Prices

Defence BEML Wins ₹157 Crore Order From Loram Rail Maintenance India To Manufacture Switch Rail...

Defence BEML Wins ₹157 Crore Order From Loram Rail Maintenance India To Manufacture Switch Rail...

Domestic Institutional Investors Pump $81.3 Billion Into Indian Equities, Surpassing Full‑Year...

Domestic Institutional Investors Pump $81.3 Billion Into Indian Equities, Surpassing Full‑Year...